Show All Answers
There are three steps to getting the vaccine:
Not all healthcare providers are participating in vaccine administration, but there are many different types of providers administering the vaccine, including:
If you are currently eligible for a vaccine and need help finding a provider, check the website of your local public health department or contact them directly.
The national rollout of the COVID-19 vaccine has been slower than anticipated, and the federal government has not delivered as many doses across the country as originally stated. There was also a lag in reporting between state and federal systems that made Kansas’ early vaccine administration numbers appear lower than they actually were. Current vaccine distribution data shows Kansas performing in line with most of the other states. Kansas is continuously improving the vaccine distribution process and expects to achieve the Governor’s goal of vaccinating all Kansans in 2021. To check the current status of the vaccine program in Kansas, visit the dashboard on this website.
The COVID-19 vaccine dashboard includes data on doses distributed and administered in Kansas. It is updated on Mondays, Wednesdays and Fridays at 12:30 pm CT.
Kansas is in Phase 2 for vaccinations, which includes persons aged 65+, congregate settings, high-contact critical workers and unvaccinated Kansans from Phase 1. Learn more about availability and timelines.
While federal vaccine supply is low, healthcare workers; residents or patients in long-term care (LTC), senior housing or LTC-supported independent living; and workers critical to pandemic response continuity are prioritized for Phase I.
Healthcare workers include but are not limited to the following:
Workers critical to pandemic response continuity are defined at the county level. If you have questions about your eligibility, contact your local public health department or call KDHE at 866-534-3463 or email. For additional information on the timelines and phases, refer to the Vaccine Prioritization Plan.
While federal vaccine supply is low, Phase 2 includes persons aged 65+, high-contact critical workers and congregate settings.
High-contact critical workers include but are not limited to the following:
Congregate settings include but are not limited to the following:
If you have questions about your eligibility, contact your local public health department or call KDHE at 866-534-3463 or email. For additional information on the timelines and phases, refer to the Vaccine Prioritization Plan.
Please remain patient as the federal vaccine supply is low. The decision to move to a new vaccination phase at the state level will be announced through multiple channels, including this website, KansasVaccine.gov, as well as the Governor’s press releases and local media outlets.
Your local public health department does have the flexibility to move to the next phase based on available supply, vaccine administration and anticipated patient demand. Stay updated on what’s happening in your community by following your local public health department or federally qualified health center on social media and by checking their website. You can also contact your local health department directly.
The federal vaccine supply is still very limited, so Kansas is administering COVID vaccinations in alignment with the phases outlined in the Vaccine Prioritization Plan. An approximate timeline is associated with each phase; however, it is subject to change based on federal vaccine supply. While the specific timeline cannot be guaranteed, the goal is to vaccinate all Kansans who want to be vaccinated this year.
Providers have been encouraged to implement some form of patient sub-group verification, such as employer letters, age checks wherever easy and accessible, self-reported surveys or screening online or on-site. Verify your provider’s screening requirements before going to your appointment. If you foresee any challenges to providing this type of identification, please contact the vaccine provider, your local public health department or call KDHE at 866-534-3463 or email.
Although universities are not specifically included in Kansas Phase 2 (or CDC phase 1b), local public health departments may determine that it is appropriate to include them under Phase 2. For example, some university faculty or staff that fit under the critical worker criteria -- workers providing critical services who are at a higher risk of being infected because their jobs require consistent, close contact with a large number of individuals, and who are not able to work remotely -- may qualify for Phase 2, as determined by their local public health department. For additional information on the timelines and phases, refer to the Vaccine Prioritization Plan.
The Vaccine Prioritization Plan accounts for all Kansans, so if you do not qualify for an earlier phase based on your profession or medical condition, then you would qualify for a later phase based on your age. Find the latest information in the Vaccine Prioritization Plan.
The COVID-19 vaccine is free to all Kansans and no insurance is required. Healthcare facilities are permitted to charge an administration fee to administer the vaccine, but Kansans cannot be denied a vaccine if they cannot afford the administration fee or do not have insurance.
Healthcare facilities are permitted to charge an administration fee for the COVID-19 vaccine; however, Kansans cannot be denied a vaccine if they cannot afford the administration fee or do not have insurance. If you are eligible for the vaccine in the current phase of availability but are turned away for not paying, please call KDHE at 866-534-3463 or email.
Alternatively, you may contact the Kansas Insurance Department’s Consumer Assistance Division by phone at 800-432-2484, by email, or by filing a complaint on their website
There is no guarantee of recovery and the long-term effects on people who have had the virus is unknown. The vaccine, like other vaccines, has the greatest ability to stop the spread of the virus.
Both currently approved vaccines have greater than 90% effectiveness in clinical trials.
The immunity duration is currently unknown.
Vaccines have proven to be greatly effective in eliminating or significantly decreasing the impact of many diseases.
Yes, you need to be vaccinated even if you’ve had COVID-19 because we are seeing reinfections.
No, starting the process over is not necessary if you have missed the second dose at the recommended time.
COVID-19 is not a hoax and neither is the vaccine. Medical professionals recommend getting vaccinated.
No, you cannot get COVID-19 from the vaccine.
Yes, you should get vaccinated even if you’ve had COVID-19 because we are seeing evidence of reinfection.
Both the Pfizer and Moderna vaccines use messenger RNA (mRNA) to encourage your cells to initiate an immune response to COVID-19. Our body relies on proteins every day to keep us healthy. Our body uses mRNA to tell our cells which proteins to make - antibodies in this case. Vaccines that use mRNA are typically quicker and easier to produce, which has helped accelerate the COVID-19 vaccine development process.
The ingredients used in the mRNA vaccines are simple. They contain mRNA, as well as lipids to ensure safe delivery of the mRNA to initiate an immune response. Although the Food and Drug Administration (FDA) approved adjuvants (aluminum salts) and preservatives (ethlymercury) have a history of safe use in vaccines, they were not used by Pfizer or Moderna in this vaccine technology.
To date, the vaccines in trial have been tested on tens of thousands of people and have passed safety requirements in Phase I and Phase II trials. As an additional layer of checks and balances, an external advisory board of medical and research professionals using additional public health data will review final COVID-19 vaccine data.
Clinical trials are an important part of determining vaccine safety and effectiveness. Currently, phase 3 clinical trials are underway for 4 vaccines involving thousands of participants. The purpose of clinical trials is to generate scientific data and other information for the Food and Drug Administration to review and base their recommendations on.
Vaccine safety monitoring systems are in place to collect side effect data. If an unexpected adverse event is seen, experts quickly study it further to assess whether it is a true safety concern that warrants changes in U.S. vaccine recommendations. This monitoring is critical to help ensure that the benefits continue to outweigh the risks for people who receive vaccines.
America’s best medical and research professionals have been working for years on coronavirus vaccines for SARS and MERS. While SARS and MERS are different than COVID-19, they belong to the coronavirus family. The lessons learned through those developments are being applied today.
Although the timeline has been accelerated, the integrity of the trial and approval processes have remained. Scientists had a head start on developing the COVID-19 vaccine, using their experience from previous coronavirus vaccine efforts. Another way scientists preserved safety and saved time was by working on efforts simultaneously, rather than one after another like the traditional process. For example, COVID-19 vaccines were in Phase III clinical trials at the same time they were being manufactured. When it was proven safe and effective, the manufactured vaccines were deployed. If the vaccines don’t pass the approval process, which is verified by an independent committee of health experts, the unproven vaccines won’t be used.
You cannot get COVID-19 from the vaccine. Every day, a healthy immune system successfully fights off thousands of germs. Antigens are parts of germs that cause the body’s immune system to go to work to build antibodies, which fight off diseases. The antigens in vaccines come from the germs themselves, but the germs are weakened or killed so they cannot cause serious illness. Even if people receive several vaccinations in one day, vaccines contain only a tiny fraction of the antigens they encounter every day in their environment. Vaccines stimulate the immune system to produce antibodies to fight off serious vaccine-preventable diseases.
Influenza and COVID-19 (SARS-CoV-2) belong to two different RNA virus families, so one vaccine is not interchangeable for another. Influenza belongs to the Orthomyxoviridae family, while SARS-CoV-2 is classified in the Coronaviridae family. Both Influenza and SARS-CoV-2 rely on different protein layers to initiate responses. Influenza uses two surface antigens, while SARS-CoV-2 uses spike proteins, so their immunization approaches are different.
COVID-19 vaccines were created using mRNA technology, which provides a set of instructions to your cells to create an immune response specific to COVID-19. Medical doctors independent of the vaccine development teams have verified that using mRNA will not alter the DNA of our body’s cells. They do not introduce DNA into your body. Learn more.
Pfizer’s vaccine was approved for ages 16 and older. Moderna’s vaccine has been approved for those 18 and older. The vaccines are not recommended for individuals who have experienced a serious reaction, such as anaphylaxis, to a prior dose of a COVID-19 vaccine or to any of its components. For information on vaccine components, refer to the manufacturers’ package inserts from Pfizer and Moderna.
The ingredients used in the mRNA vaccines developed by Pfizer and Moderna are simple. They contain mRNA, as well as lipids to ensure safe delivery of the mRNA that will initiate an immune response. Although FDA approved adjuvants (aluminum salts) and preservatives (ethylmercury) have a history of safe use in vaccines, they were not used by Pfizer and Moderna in this vaccine technology. The vaccines do not include fetal tissue.
Among vaccine recipients during the Pfizer clinical trials, 8.8% reported experiencing any reaction they considered to interfere with daily activity; the most common symptoms were fatigue (4.2%), headache (2.4%), muscle pain (1.8%), chills (1.7%), and injection site pain (1.4%). More people experienced these side effects after the second dose.Among vaccine recipients during the Moderna clinical trials, 9.1% reported local injection site reaction and 16.5% reported side effects, with the most common including fever, headache, fatigue and muscle aches and pains.No specific safety concerns were identified for the Pfizer and Moderna vaccines in subgroup analyses by age, race, ethnicity, underlying medical conditions, or previous SARS-CoV-2 infection.
Yes, it is recommended that even vaccinated individuals practice an abundance of caution by continuing to wear a mask, social distance, wash their hands and avoid large gatherings -- especially indoors.
COVID-19 is a deadly disease that causes severe illness – and in some cases, long term symptoms that we have yet to fully understand. The COVID-19 vaccine has been created to decrease death and severe illness.
Although a high percentage of people recover from COVID-19, some are hospitalized and experience severe illness. It is also somewhat common to have the virus but never experience symptoms, and it’s possible to spread the virus to others even when symptoms are not present. When you make the choice to be vaccinated, you are protecting not only yourself but also those around you from the chance of death and severe illness.
Yes. We are seeing evidence of reinfection in patients. Early evidence suggests natural immunity from SARS-CoV-2 may not last very long, but more studies are needed to better understand this. Vaccination should not occur until the patient has met the criteria to discontinue isolation.
No, COVID-19 vaccines will not be mandated in Kansas at this time.
Coronavirus vaccines have been in development for almost two decades.
To get vaccinated, you only need basic demographic data, which includes your name and contact information.
The primary purpose in collecting information about you is to ensure you receive the appropriate booster dose at the appropriate time, as well to provide ongoing proof of your vaccination.
The COVID-19 vaccine is safe. Please read through our Vaccine Safety page for more information on the safety of both COVID-19 vaccines.
According to the U.S. Food and Drug Administration (FDA), the Pfizer-BioNTech COVID-19 vaccine ingredients include:
According to the FDA, the Moderna COVID-19 vaccine ingredients include:
Go to the U.S. Food and Drug Administration website for:
Yes, until all populations are vaccinated, please continue to take precautions.
There is a wide range of demographics available in the U.S. Food and Drug Administration (FDA) summary.
The current vaccines are not approved for children under the age of 16.
There is limited data regarding the vaccine and pregnant women. Learn more from the Centers for Disease Control and Prevention (CDC) website.
Approved COVID-19 vaccine providers must apply for approval providing information and proof of current valid medical license in Kansas.
The vaccines have gone through rigorous clinical trials and the history of success of vaccines in stopping viruses and other diseases effectively saving lives.
Patient care is very nuanced, so the FDA advises telling your vaccination provider about all of your medical conditions, including but not limited to the following:
If you have been previously infected with COVID-19, vaccination is recommended; however, the CDC advises waiting 90 days after treatment for COVID-19 symptoms with monoclonal antibodies or convalescent plasma. If you are currently in quarantine due to potential exposure to COVID-19, please wait 14 days after your exposure to get vaccinated to ensure that you do not have COVID-19.
For more information, refer to the Pfizer EUA Factsheet; Moderna EUA Factsheet and CDC COVID-19 Vaccination FAQ.